STLN
The Oncology Institute, Inc.
6.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | -20.0% | -17.5% | -4.7% | |
| – | +10.0% | -21.7% | +0.3% | |
| – | +139.0% | +48.3% | -32.4% | |
| – | – | – | – | |
| – | +6.4% | +14.1% | +22.7% | |
| – | +47.7% | -26.6% | +68.1% | |
| – | -66.2% | +0.0% | +0.0% | |
| – | -0.3% | -17.3% | -25.6% | |
| – | +9.9% | +11.1% | +6.7% | |
| – | +17.1% | +50.1% | +35.9% | |
| – | – | – | – | |
| – | +54.0% | +68.6% | +77.5% | |
| – | +7.7% | +7.3% | -16.9% | |
| – | -53.7% | -93.7% | -538.0% | |
| – | – | – | – | |
| – | +1.2% | +2.1% | +22.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.